Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
1-Year Return 51.86%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+2.65%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$191B
AUM Growth
-$14.1B
Cap. Flow
-$5.18B
Cap. Flow %
-2.71%
Top 10 Hldgs %
39.72%
Holding
509
New
37
Increased
114
Reduced
204
Closed
17

Top Sells

1
BABA icon
Alibaba
BABA
$2.33B
2
TSLA icon
Tesla
TSLA
$1.55B
3
MRNA icon
Moderna
MRNA
$1.41B
4
AMZN icon
Amazon
AMZN
$884M
5
NTES icon
NetEase
NTES
$692M

Sector Composition

1 Consumer Discretionary 27.71%
2 Healthcare 26.02%
3 Technology 19.32%
4 Communication Services 12.04%
5 Financials 4.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ROL icon
376
Rollins
ROL
$27.4B
$20K ﹤0.01%
562
-43
-7% -$1.53K
PLAN
377
DELISTED
Anaplan, Inc.
PLAN
$19K ﹤0.01%
306
EBS icon
378
Emergent Biosolutions
EBS
$416M
$19K ﹤0.01%
385
-38
-9% -$1.88K
INSM icon
379
Insmed
INSM
$29.9B
$19K ﹤0.01%
707
-80
-10% -$2.15K
VC icon
380
Visteon
VC
$3.38B
$19K ﹤0.01%
+200
New +$19K
BLK icon
381
Blackrock
BLK
$171B
$18K ﹤0.01%
21
HD icon
382
Home Depot
HD
$408B
$18K ﹤0.01%
56
-5
-8% -$1.61K
QDEL icon
383
QuidelOrtho
QDEL
$1.87B
$18K ﹤0.01%
128
SLAB icon
384
Silicon Laboratories
SLAB
$4.35B
$18K ﹤0.01%
127
VIAV icon
385
Viavi Solutions
VIAV
$2.63B
$18K ﹤0.01%
1,142
VRNT icon
386
Verint Systems
VRNT
$1.23B
$18K ﹤0.01%
395
NVRO
387
DELISTED
NEVRO CORP.
NVRO
$18K ﹤0.01%
154
DTIL icon
388
Precision BioSciences
DTIL
$58.8M
$17K ﹤0.01%
49
+21
+75% +$7.29K
GNTX icon
389
Gentex
GNTX
$6.12B
$17K ﹤0.01%
516
OM icon
390
Outset Medical
OM
$234M
$17K ﹤0.01%
23
SAIL
391
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$17K ﹤0.01%
388
BLUE
392
DELISTED
bluebird bio
BLUE
$16K ﹤0.01%
66
HUBB icon
393
Hubbell
HUBB
$23B
$16K ﹤0.01%
87
NCNO icon
394
nCino
NCNO
$3.55B
$16K ﹤0.01%
232
+32
+16% +$2.21K
RMBS icon
395
Rambus
RMBS
$7.93B
$16K ﹤0.01%
699
SRPT icon
396
Sarepta Therapeutics
SRPT
$1.91B
$16K ﹤0.01%
177
-28
-14% -$2.53K
THO icon
397
Thor Industries
THO
$5.83B
$16K ﹤0.01%
133
DCT
398
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$16K ﹤0.01%
355
STMP
399
DELISTED
Stamps.com, Inc.
STMP
$16K ﹤0.01%
47
-8
-15% -$2.72K
ACN icon
400
Accenture
ACN
$158B
$15K ﹤0.01%
48